{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:17:30Z","timestamp":1788985050181,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012905","name":"Department of Science and Technology of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH372"],"award-info":[{"award-number":["ZR2022QH372"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.redox.2026.104341","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:48:43Z","timestamp":1786463323000},"page":"104341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lactylation at the crossroads: Bridging metabolic rewiring and ferroptotic vulnerability in cancer"],"prefix":"10.1016","volume":"96","author":[{"given":"Yali","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-8866","authenticated-orcid":false,"given":"Hai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104341_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.redox.2026.104341_bib2","first-page":"1029","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science. United States"},{"key":"10.1016\/j.redox.2026.104341_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib4","article-title":"Targeting lactate metabolism in cancer therapy: the mechanism of lactylation modification and prospects of therapeutic strategies","author":"Xing","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.redox.2026.104341_bib5","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 years of the warburg effect: a cancer metabolism endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104341_bib6","first-page":"1","article-title":"Deciphering the link: ferroptosis and its role in glioma","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104341_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","article-title":"Prospects for ferroptosis therapies in cancer","volume":"6","author":"Ubellacker","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.redox.2026.104341_bib8","first-page":"1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer [Internet]. BioMed Central"},{"key":"10.1016\/j.redox.2026.104341_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem Sci [Internet]. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib10","first-page":"6124","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med [Internet]. John Wiley & Sons, Ltd"},{"key":"10.1016\/j.redox.2026.104341_bib11","article-title":"Lactate in the tumor microenvironment: a rising star for targeted tumor therapy","volume":"10","author":"Li","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.redox.2026.104341_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol Metab [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann N Y Acad Sci [Internet]. John Wiley & Sons, Ltd"},{"key":"10.1016\/j.redox.2026.104341_bib14","article-title":"Iron metabolism and ferroptosis in health and diseases: the crucial role of mitochondria in metabolically active tissues","volume":"140","author":"Catapano","year":"2025","journal-title":"J Nutr Biochem [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/antiox10030491","article-title":"Implication of dietary iron-chelating bioactive compounds in molecular mechanisms of oxidative stress-induced cell ageing","author":"Barbouti","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104341_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the fenton reaction","volume":"82\u201383","author":"Winterbourn","year":"1995","journal-title":"Toxicol Lett [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"508","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104341_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104341_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104341_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104341_bib22","article-title":"Protein lysine acetyltransferase CBP\/p300: a promising target for small molecules in cancer treatment","volume":"171","author":"Gou","year":"2024","journal-title":"Biomed Pharmacother [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib25","first-page":"1","article-title":"Emerging roles of lysine lactyltransferases and lactylation","author":"Zong","year":"2025","journal-title":"Nat Cell Biol. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molcel.2024.12.012","article-title":"Metabolism-driven chromatin dynamics: molecular principles and technological advances","volume":"85","author":"Sahu","year":"2025","journal-title":"Mol Cell. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib27","first-page":"1","article-title":"The emerging role of protein L-lactylation in metabolic regulation and cell signalling","author":"Ren","year":"2025","journal-title":"Nat Metab. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib28","first-page":"N","article-title":"Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment","volume":"12","author":"Fu","year":"2026","journal-title":"Hepatoma Res. OAE Publishing Inc."},{"key":"10.1016\/j.redox.2026.104341_bib29","article-title":"Lactylation and tumor immune regulation: insights from recent studies","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol. Frontiers Media SA"},{"key":"10.1016\/j.redox.2026.104341_bib30","article-title":"Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci Adv. American Association for the Advancement of Science"},{"key":"10.1016\/j.redox.2026.104341_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-025-02519-z","article-title":"Lactate: elucidating its indispensable role in human health","volume":"25","author":"Zhang","year":"2026","journal-title":"Mol Cancer [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-024-02205-6","article-title":"Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer. Springer"},{"key":"10.1016\/j.redox.2026.104341_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41392-026-02757-7","article-title":"Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications","volume":"11","author":"Yang","year":"2026","journal-title":"Signal Transduct Target Ther [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib34","article-title":"Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2026","journal-title":"Sci Adv [Internet]. American Association for the Advancement of Science"},{"key":"10.1016\/j.redox.2026.104341_bib35","first-page":"5632","article-title":"Regulation of inflammatory responses by pH-dependent transcriptional condensates","volume":"188","author":"Wu","year":"2025","journal-title":"Cell [Internet]. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.redox.2026.104341_bib37","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.7150\/ijbs.130059","article-title":"GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis","volume":"22","author":"Sun","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.redox.2026.104341_bib38","article-title":"EP300-mediated H3K18la regulation of METTL3 promotes macrophage ferroptosis and atherosclerosis through the m6A modification of SLC7A11","volume":"1869","author":"Chen","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-General Subj. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib39","first-page":"3","article-title":"Enhanced glycolysis-derived lactate promotes microglial activation in Parkinson's disease via histone lactylation","volume":"11","author":"Qin","year":"2025","journal-title":"npj Park Dis. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem Biol [Internet]. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib42","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104341_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.redox.2026.104341_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s42003-021-01765-3","article-title":"Photoreceptor metabolic reprogramming: current understanding and therapeutic implications","volume":"4","author":"Pan","year":"2021","journal-title":"Commun Biol [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib46","article-title":"Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury","volume":"74","author":"Wu","year":"2024","journal-title":"Redox Biol. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41419-026-08494-7","article-title":"Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerability","volume":"17","author":"Yang","year":"2026","journal-title":"Cell Death Dis. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s12276-025-01410-7","article-title":"Protein lactylation in cancer: mechanisms and potential therapeutic implications","volume":"57","author":"Rho","year":"2025","journal-title":"Exp Mol Med [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: a kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol Cell. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol Cell [Internet]"},{"key":"10.1016\/j.redox.2026.104341_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.703465","article-title":"A novel oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment","volume":"11","author":"Pilanc","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.redox.2026.104341_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10495-025-02247-1","article-title":"Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications","volume":"31","author":"Zhou","year":"2026","journal-title":"Apoptosis. Springer"},{"key":"10.1016\/j.redox.2026.104341_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41419-025-08263-y","article-title":"AGR2 suppresses ferroptosis via the p53\/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer","volume":"16","author":"Jian","year":"2025","journal-title":"Cell Death Dis. Nature Publishing Group"},{"key":"10.1016\/j.redox.2026.104341_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45284-z","article-title":"SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma","volume":"13","author":"Shan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104341_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-026-01117-2","article-title":"METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers","author":"Xu","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.redox.2026.104341_bib56","article-title":"The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications","volume":"15","author":"Su","year":"2024","journal-title":"Front Immunol. Frontiers Media SA"},{"key":"10.1016\/j.redox.2026.104341_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","article-title":"JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases","volume":"25","author":"Dai","year":"2025","journal-title":"Cancer Cell Int. Springer"},{"key":"10.1016\/j.redox.2026.104341_bib58","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.2147\/JIR.S506964","article-title":"The dual roles of STAT3 in ferroptosis: mechanism, regulation and therapeutic potential","author":"Xie","year":"2025","journal-title":"J Inflamm Res. Taylor & Francis"},{"key":"10.1016\/j.redox.2026.104341_bib59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jid.2022.09.004","article-title":"The p300\/CBP inhibitor A485 normalizes psoriatic fibroblast gene expression in vitro and reduces psoriasis-like skin inflammation in vivo","volume":"143","author":"Kim","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.redox.2026.104341_bib60","volume":"vol. 10","author":"Hsu","year":"2021"},{"key":"10.1016\/j.redox.2026.104341_bib61","first-page":"42","article-title":"Lactylation-mediated ferroptosis: a novel mechanism and therapeutic prospects in human diseases","volume":"57","author":"Lin","year":"2025","journal-title":"Int J Mol Med. DA Spandidos"},{"key":"10.1016\/j.redox.2026.104341_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311278","article-title":"Targeting lactylation for cancer: mechanisms, effects, and therapeutic prospects","volume":"26","author":"Chang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104341_bib63","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1039\/D2NA00719C","article-title":"Recent trends in emerging strategies for ferroptosis-based cancer therapy","volume":"5","author":"Yu","year":"2023","journal-title":"Nanoscale Adv. Royal Society of Chemistry"},{"key":"10.1016\/j.redox.2026.104341_bib64","first-page":"207","article-title":"Ferroptosis: from basic research to clinical therapeutics in hepatocellular carcinoma","volume":"11","author":"Huang","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.redox.2026.104341_bib65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41419-025-07663-4","article-title":"TTC36 promotes proliferation and drug resistance in hepatocellular carcinoma cells by inhibiting c-Myc degradation","volume":"16","author":"Shao","year":"2025","journal-title":"Cell Death Dis. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib66","first-page":"2688","article-title":"The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.redox.2026.104341_bib68","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem Biol. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib69","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/molecules28062636","article-title":"Nature-inspired bioactive compounds: a promising approach for ferroptosis-linked human diseases?","volume":"28","author":"El Hajj","year":"2023","journal-title":"Molecules. MDPI"},{"key":"10.1016\/j.redox.2026.104341_bib70","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1021\/acschembio.3c00293","article-title":"Comparative analysis of drug-like EP300\/CREBBP acetyltransferase inhibitors","volume":"18","author":"Crawford","year":"2023","journal-title":"ACS Chem Biol. ACS Publications"},{"key":"10.1016\/j.redox.2026.104341_bib71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib72","article-title":"p300: expanding beyond acetylation to mastermind lactylation-dependent tumorigenesis","volume":"14","author":"Jiang","year":"2026","journal-title":"Front Cell Dev Biol. Frontiers Media SA"},{"key":"10.1016\/j.redox.2026.104341_bib73","first-page":"2386","article-title":"Therapeutic targeting of the p300\/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene. Nature Publishing Group UK London"},{"key":"10.1016\/j.redox.2026.104341_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189599","article-title":"Genetic mutations and inhibitors of p300 and CBP","author":"Robaszkiewicz","year":"2026","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer. Elsevier"},{"key":"10.1016\/j.redox.2026.104341_bib75","series-title":"Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma","author":"Silva","year":"2025"},{"key":"10.1016\/j.redox.2026.104341_bib76","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","article-title":"A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice","volume":"33","author":"Chatterjee","year":"2013","journal-title":"J Neurosci. Society for Neuroscience"},{"key":"10.1016\/j.redox.2026.104341_bib77","article-title":"Comment on \u201cLactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer.\u201d","volume":"80","author":"Mehta","year":"2025","journal-title":"Clinics. SciELO Brasil"},{"key":"10.1016\/j.redox.2026.104341_bib78","article-title":"Transforming cancer diagnostics: the emergence of liquid biopsy and epigenetic markers","volume":"6","author":"Saha","year":"2025","journal-title":"MedComm. Wiley Online Library"},{"key":"10.1016\/j.redox.2026.104341_bib79","first-page":"291","article-title":"Chromatin-and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery","volume":"102","author":"Penny","year":"2024","journal-title":"Biochem Cell Biol. Canadian Science Publishing 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7"},{"key":"10.1016\/j.redox.2026.104341_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/ijms27010149","article-title":"Mass spectrometry quantification of epigenetic changes: a scoping review for cancer and beyond","volume":"27","author":"Comito","year":"2025","journal-title":"Int J Mol Sci. MDPI"},{"key":"10.1016\/j.redox.2026.104341_bib81","article-title":"High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development","volume":"301","author":"Van den Ackerveken","year":"2025","journal-title":"J Biol Chem. Elsevier"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172600340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172600340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:58:30Z","timestamp":1788983910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172600340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":81,"alternative-id":["S221323172600340X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104341","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactylation at the crossroads: Bridging metabolic rewiring and ferroptotic vulnerability in cancer","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104341"}}